GenomSys Sets its New Headquarters at the “Biopôle” in Lausanne

| By | DNA, Life Sciences
0
332

GenomSys has moved two of its teams to the BioPôle in Lausanne, to support the company’s growth and improve its accessibility to the Life Sciences community.

The Biopôle was chosen for its high concentration of renowned life-sciences experts, a community combining key actors from industry and academia. It hosts over 100 of Switzerland’s most innovative Life Sciences & BioTech companies, who regularly collaborate on research projects in fields including pharmacogenomics, diagnostics, precision medicine and agrigenomics.

“Our new, larger office reflects our mindset – modern, exciting and future-oriented, and it’s aligned with our ambitious market and workforce growth objectives. We are delighted to now be closer to our customers, including the laboratories where they perform DNA extraction, preparation, and sequencing. Our move opens up opportunities for co-learning and collaboration”, says Stephane Doutriaux, CEO at GenomSys.

“The physical proximity to labs and research centers benefits our innovation cycle as we work more closely with those that operate NGS sequencers”, adds GenomSys’ CTO Claudio Alberti.

Switzerland’s Health Valley is a world-class cluster of BioTech companies, research centers and innovation support structures, regrouping over 25,000 employees in the Lake Geneva region of Switzerland. The area strives to boost the Life Sciences ecosystem by establishing bridges between its ambassadors to promote innovation, technology and business.

SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.